Europe Medical Foods Market size is anticipated to hit USD 7.2 billion by 2030
Europe Medical Foods Industry Overview
The Europe medical foods market size was valued at USD 5.6 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 2.9% from 2022 to 2030.
The rise in the prevalence of chronic diseases, the rapidly growing geriatric population, and governmental authorities focusing on reducing malnutrition are key factors responsible for the growth of the medical foods market. According to WHO the burden of disease in Europe associated with poor nutrition is rising. According to Eurostat, more than one-fifth of the EU population was 65 and above, as of 2020.
Gather more insights about the market drivers, restrains and growth of the Europe Medical Foods Market
The European Union’s (EU) declining birth rate and increase in overall life expectancy have resulted in an increase in the geriatric population, and will continue to rise in the coming decades. The majority of chronic diseases which affect the geriatric population are also on the rise, management of these diseases with respect to nutrition and the focus of healthcare practitioners has shifted towards medical foods, conditions like malnutrition or inability to utilize naturally occurring food to meet nutritional requirements also drive the growth of this market for medical foods in Europe.
Neurological disorders like multiple sclerosis, stroke, dementia, and Parkinson’s cause severe nutritional deficits in the patients, resulting in the need for easy to digest and administer foods that will not only complete the nutritional requirements but also be easy to use by patients, which is further strengthening the growth of the market for medical foods in Europe. With an increase in the number of infants suffering from congenital metabolism disorders and nutritional deficiency has also risen, infant-friendly medical foods are also capturing the market.
Browse through Grand View Research's Pharmaceuticals Industry Research Reports
- Plant-based Excipients Market: Plant based excipients are substances or compounds that affect the quality of the finished product in addition to the active pharmaceutical ingredients and packaging components.
- Generic Pharmaceuticals Market: The global generic pharmaceuticals market was valued at USD 361.7 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 8.3% from 2023 to 2030.
Key Companies Profile
Some of the prominent players in the Europe medical foods market include:
- Danone
- Nestlé
- Abbott
- Fresenius Kabi AG
- Targeted Medical Pharma, Inc.
- Mead Johnson & Company, LLC
Order a free sample PDF of Europe Medical Foods Market Intelligence Study, published by Grand View Research.
Comments
Post a Comment